TRULICITY 1.5 MG - AN OVERVIEW

one) and Drug Interactions (7)]. The risk of hypoglycemia may very well be reduced by a reduction during the dose of sulfonylurea (or other concomitantly administered insulin secretagogue) or insulin. Notify patients using these concomitant drugs of the potential risk of hypoglycemia and teach them about the signs and signs and symptoms of hypoglyc